← Back to dashboard
ISRG Robotics Surgical robotics leader Open in compare

Intuitive Surgical

Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.

Live metrics are partially unavailable

1 of 20 live fields are unavailable right now. The chart, thesis sections, and source links still make the page usable.

19 live 1 unavailable
Price $477.97 Live
1D Change -0.41% 1 day
Market Cap $169.76B Live
Enterprise Value $164.10B Current
Trailing P/E 60.6 TTM
Forward P/E 41.8 Forward
Price / Sales 16.9 TTM
EV / Revenue 16.3 TTM
Revenue Growth 18.8% YoY latest qtr
Earnings Growth 16.6% YoY latest qtr
Gross Margin 66.0% TTM
Operating Margin 30.2% TTM
Net Margin 28.4% TTM
ROE 16.7% TTM
Free Cash Flow $2.27B TTM
FCF Margin 22.6% TTM
Debt / Equity 0.95x Latest qtr
Current Ratio 4.88x Latest qtr
Dividend Yield Annualized
Next Earnings Apr 21, 2026 Calendar

Metric timing

This page mixes live market data, trailing fundamentals, and latest reported statement data.

Live / market snapshot

Price, 1D change, market cap, and enterprise value are current market-based figures.

TTM / forward

Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.

Latest quarter / dividend cadence

Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.

Revenue $10.06B Dec 31, 2025

latest annual revenue

Revenue $2.87B Dec 31, 2025

latest quarterly revenue

Net Income $2.86B Dec 31, 2025

latest annual profit

Net Income $794.8M Dec 31, 2025

latest quarterly profit

Dividend / Share $0.00 No regular dividend

annualized per share

Last Dividend No dividend history

latest ex-dividend cash amount

Price chart

Data loads live when the page opens.

Latest headlines

Recent company headlines. Each link opens the original article in a new tab.

Insider Monkey Mar 21, 2026
Is Intuitive Surgical, Inc. (ISRG) A Good Stock To Buy Now?

Is ISRG a good stock to buy? We came across a bullish thesis on Intuitive Surgical, Inc. on MTC’s Substack. In this article, we will summarize the bulls’ thesis on ISRG. Intuitive Surgical, Inc.’s share was trading at $483.46 as of March 16th. ISRG’s trailing and forward P/E were 59.99 and 47.39 respectively according to Yahoo Finance. Intuitive […]

Insider Monkey Mar 21, 2026
Jim Cramer on Intuitive Surgical: “It’s Just Gotten Too Expensive Per Share”

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks mentioned during the show, as we cover everything Jim Cramer said about the oversold market. A caller asked which of the three metrics is most important for the company: procedure growth, system placements, or hospital utilization. Cramer replied: It’s hospital utilization, and what gets me down […]

Zacks Mar 20, 2026
Should You Continue to Hold Insulet Stock in Your Portfolio?

PODD's Omnipod 5 momentum and strong growth outlook highlight upside, but macro pressures and rising competition could challenge its near-term performance.

Zacks Mar 20, 2026
Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio

AMN rides MSP momentum, AI investments and surging labor disruption demand, but pricing pressure and volatile healthcare trends cloud its near-term outlook.

Zacks Mar 20, 2026
GEHC Acquires Intelerad to Boost Cloud-First, AI Imaging Capabilities

GE HealthCare completes the $2.3B Intelerad deal to expand AI-driven imaging, boost recurring revenues and strengthen its cloud-first healthcare platform.

Zacks Mar 20, 2026
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments

GKOS launches Epioxa, the first FDA-approved topical keratoconus therapy, targeting an underserved market and positioning the company for long-term growth.

Why it could benefit going forward

  • Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
  • Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
  • This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.

Moat / edge

  • Large installed base and deep surgeon training ecosystem.
  • Recurring revenue from instruments, accessories, and service.
  • Years of lead time and brand strength in robotic-assisted surgery.

What to watch

  • Procedure growth and system placements.
  • Adoption of newer da Vinci platforms and adjacent products.
  • Gross-margin resilience as the business scales.

Key risks

  • Premium valuation can leave less room for execution misses.
  • Hospital capital-spending cycles still matter.

Business snapshot

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.